{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:17:16Z","timestamp":1760660236129,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3943,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1053\/rmed.2002.1348","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T16:41:17Z","timestamp":1034008877000},"page":"784-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A new HFA-134a propellant in the administration of inhaled BDP via the Jet\u00ae spacer: controlled clinical trial vs the conventional CFC"],"prefix":"10.1053","volume":"96","author":[{"given":"V","family":"VONDRA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"SLADEK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"KOTASOV\u00c1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"TE R\u0306","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"ROSSETTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"CANTINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/rmed.2002.1348_RF1","first-page":"75","article-title":"The environmental impact of inhaled aerosols","volume":"4","author":"Pavia","year":"1994","journal-title":"Eur Respir Rev"},{"key":"10.1053\/rmed.2002.1348_RF2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jam.1995.8.Suppl_1.S-13","article-title":"Montreal protocol and essential use exemptions","volume":"8","author":"D'Souza","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1053\/rmed.2002.1348_RF3","unstructured":"Result of co-ordinated review of 1, 1, 1, 2-tetrafluoroethane HFA-134a, 1994"},{"key":"10.1053\/rmed.2002.1348_RF4","first-page":"1210","article-title":"Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane\u2013beclomethasone extrafine inhalation aerosol), in asthma","volume":"105","author":"Van der Burgt","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/rmed.2002.1348_RF5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5173(99)00137-4","article-title":"Modulation of aerosol clouds produced by pressurised inhalation aerosols","volume":"186","author":"Brambilla","year":"1999","journal-title":"Int J Pharmacol"},{"key":"10.1053\/rmed.2002.1348_RF6","unstructured":"Global Strategy for Asthma Management and Prevention, National Institute of Health, National Heart, Lung and Blood Institute, 1995"},{"key":"10.1053\/rmed.2002.1348_RF7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"year":"1995","series-title":"nQuery Advisor User's Guide","author":"Elashoff","key":"10.1053\/rmed.2002.1348_RF8"},{"key":"10.1053\/rmed.2002.1348_RF9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/rmed.2000.1008","article-title":"Clinical equivalence of salmeterol\/fluticasone propionate in combination (50\/100 \u03bc g twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma","volume":"95","author":"Bateman","year":"2001","journal-title":"Respir Med"},{"key":"10.1053\/rmed.2002.1348_RF10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/rmed.1999.0631","article-title":"Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulation of inhaled beclomethasone (letters to the Editor)","volume":"94","author":"Lipworth","year":"2000","journal-title":"Respir Med"},{"key":"10.1053\/rmed.2002.1348_RF11","first-page":"1060","article-title":"A study on the deposition pattern of radiolabeled aerosol","volume":"8","author":"Matthys","year":"1995","journal-title":"Respir J"},{"key":"10.1053\/rmed.2002.1348_RF12","first-page":"220","article-title":"Beclomethasone dipropionate given to adult asthmatics through a new spacer device: effects of high-dose administration","volume":"13","author":"Girbino","year":"1996","journal-title":"Adv Ther"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461110291348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461110291348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:02:51Z","timestamp":1760608971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461110291348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S095461110291348X"],"URL":"https:\/\/doi.org\/10.1053\/rmed.2002.1348","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new HFA-134a propellant in the administration of inhaled BDP via the Jet\u00ae spacer: controlled clinical trial vs the conventional CFC","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/rmed.2002.1348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}